• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Erasca Inc.

    10/29/24 8:28:26 PM ET
    $ERAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ERAS alert in real time by email
    SC 13G/A 1 d899571dsc13ga.htm SC 13G/A SC 13G/A

     

     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 3)*

     

     

    Erasca, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    29479A108

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐

    Rule 13d-1(b)

     

    ☐

    Rule 13d-1(c)

     

    ☒

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 29479A108    Schedule 13G    Page 1 of 8

     

     1   

     Names of Reporting Persons

     

     City Hill, LLC

     2  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☐

     

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

     Sole Voting Power

     

     0

       6   

     Shared Voting Power

     

     12,899,360

       7   

     Sole Dispositive Power

     

     0

       8   

     Shared Dispositive Power

     

     12,899,360

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     12,899,360

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     4.6%

    12  

     Type of Reporting Person

     

     OO


    CUSIP No. 29479A108    Schedule 13G    Page 2 of 8

     

     1   

     Names of Reporting Persons

     

     Jonathan E. Lim

     2  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☐

     

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Canada

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

     Sole Voting Power

     

     1,547,224

       6   

     Shared Voting Power

     

     32,355,576

       7   

     Sole Dispositive Power

     

     1,547,224

       8   

     Shared Dispositive Power

     

     32,355,576

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     33,902,800

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     11.9%

    12  

     Type of Reporting Person

     

     IN


    CUSIP No. 29479A108    Schedule 13G    Page 3 of 8

     

     1   

     Names of Reporting Persons

     

     Conyee T. Lim

     2  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☐

     

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

     Sole Voting Power

     

     0

       6   

     Shared Voting Power

     

     19,456,216

       7   

     Sole Dispositive Power

     

     0

       8   

     Shared Dispositive Power

     

     19,456,216

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     19,456,216

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     6.9%

    12  

     Type of Reporting Person

     

     IN


    CUSIP No. 29479A108    Schedule 13G    Page 4 of 8

     

    ITEM 1.

    (a) Name of Issuer:

    Erasca, Inc. (the “Issuer”).

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    3115 Merryfield Row, Suite 300, San Diego, CA 92121

     

    ITEM 2.

    (a) Name of Person Filing:

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

    City Hill, LLC

    Jonathan E. Lim

    Conyee T. Lim

     

      (b)

    Address or Principal Business Office:

    The principal business address of the Reporting Persons is c/o Erasca, Inc., 3115 Merryfield Row, Suite 300, San Diego, CA 92121.

     

      (c)

    Citizenship of each Reporting Person is:

    City Hill, LLC is organized under the laws of the State of Delaware. Jonathan E. Lim is a citizen of Canada and Conyee T. Lim is a citizen of the United States.

     

      (d)

    Title of Class of Securities:

    Common stock, $0.0001 par value per share (“Common Stock”).

     

      (e)

    CUSIP Number:

    29479A108

     

    ITEM 3.

    Not applicable.


    CUSIP No. 29479A108    Schedule 13G    Page 5 of 8

     

    ITEM 4.

    Ownership.

    (a-c)

    The ownership information presented below represents beneficial ownership of Common Stock as of September 30, 2024, based upon 282,504,318 shares of Common Stock outstanding as of August 5, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 12, 2024.

     

    Reporting Person   

    Amount

    beneficially

    owned

        

    Percent

    of class:

        Sole power
    to vote or
    to direct
    the vote:
         Shared
    power to
    vote or to
    direct the
    vote:
        

    Sole power
    to dispose
    or to direct
    the
    disposition

    of:

        

    Shared

    power to

    dispose or

    to direct

    the

    disposition

    of:

     

    City Hill, LLC

         12,899,360        4.6 %      0        12,899,360        0        12,899,360  

    Jonathan E. Lim

         33,902,800        11.9 %      1,547,224        32,355,576        1,547,224        32,355,576  

    Conyee T. Lim

         19,456,216        6.9 %      0        19,456,216        0        19,456,216  

    City Hill, LLC is the record holder of 12,899,360 shares of Common Stock. Jonathan E. Lim is the Managing Partner of City Hill, LLC and as a result may be deemed to share beneficial ownership of the shares of Common Stock held of record by City Hill, LLC. Jonathan E. Lim may be deemed to beneficially own 1,547,224 shares of Common Stock underlying stock options exercisable on or within 60 days of September 30, 2024.

    In addition, Jonathan E. Lim and Conyee T. Lim serve as co-trustees of a family trust that is the record holder of 19,456,216 shares of Common Stock. As a result, each of Jonathan E. Lim and Conyee T. Lim may be deemed to share beneficial ownership of the shares of Common Stock held of record by such trust.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    Not applicable.

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.


    CUSIP No. 29479A108    Schedule 13G    Page 6 of 8

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    CUSIP No. 29479A108    Schedule 13G    Page 7 of 8

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: October 29, 2024

     

    City Hill, LLC
    By:  

    /s/ Jonathan E. Lim, M.D.

    Name:   Jonathan E. Lim, M.D.
    Title:   Managing Partner
    Jonathan E. Lim

    /s/ Jonathan E. Lim, M.D.

    Conyee T. Lim

    /s/ Conyee T. Lim, M.D.


    CUSIP No. 29479A108    Schedule 13G    Page 8 of 8

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    99    Joint Filing Agreement (previously filed).
    Get the next $ERAS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ERAS

    DatePrice TargetRatingAnalyst
    3/26/2025$5.00Outperform
    Raymond James
    11/18/2024$6.00Buy
    Jefferies
    3/11/2024$8.00Overweight
    CapitalOne
    1/5/2024$11.00 → $6.00Buy → Neutral
    BofA Securities
    10/11/2023$10.00Buy
    H.C. Wainwright
    3/30/2023$9.00Buy
    Mizuho
    2/24/2023$10.00Buy
    Goldman
    2/3/2023$15.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings